The Progression of SARS Coronavirus 2 (SARS-CoV2): Mutation in the Receptor Binding Domain of Spike Gene
0
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) is a positive-sense single-stranded RNA (+ssRNA) that causes coronavirus disease 2019 (COVID-19). The viral genome encodes twelve genes for viral replication and infection. The third open reading frame is the spike (S) gene that encodes for the spike glycoprotein interacting with specific cell surface receptor – angiotensin converting enzyme 2 (ACE2) – on the host cell membrane. Most recent studies identified a single point mutation in S gene. A single point mutation in S gene leading to an amino acid substitution at codon 614 from an aspartic acid 614 into glycine (D614G) resulted in greater infectivity compared to the wild type SARS-CoV2. We were interested in investigating the mutation region of S gene of SARS-CoV2 from Korean COVID-19 patients. New mutation sites were found in the critical receptor binding domain (RBD) of S gene, which is adjacent to the aforementioned D614G mutation residue. This specific sequence data demonstrated the active progression of SARS-CoV2 by mutations in the RBD of S gene. The sequence information of new mutations is critical to the development of recombinant SARS-CoV2 spike antigens, which may be required to improve and advance the strategy against a wide range of possible SARS-CoV2 mutations.
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) is a positive-sense single-stranded RNA (+ssRNA) that causes coronavirus disease 2019 (COVID-19). The viral genome encodes twelve genes for viral replication and infection. The third open reading frame is the spike (S) gene that encodes for the spike glycoprotein interacting with specific cell surface receptor – angiotensin converting enzyme 2 (ACE2) – on the host cell membrane. Most recent studies identified a single point mutation in S gene. A single point mutation in S gene leading to an amino acid substitution at codon 614 from an aspartic acid 614 into glycine (D614G) resulted in greater infectivity compared to the wild type SARS-CoV2. We were interested in investigating the mutation region of S gene of SARS-CoV2 from Korean COVID-19 patients. New mutation sites were found in the critical receptor binding domain (RBD) of S gene, which is adjacent to the aforementioned D614G mutation residue. This specific sequence data demonstrated the active progression of SARS-CoV2 by mutations in the RBD of S gene. The sequence information of new mutations is critical to the development of recombinant SARS-CoV2 spike antigens, which may be required to improve and advance the strategy against a wide range of possible SARS-CoV2 mutations.
참고문헌 (20)
- Crackower MA, "Angiotensin-converting enzyme 2 is an essential regulator of heart function", Nature, 417, pp.822~828 (2002)
- Zhou P, "A pneumonia outbreak associated with a new coronavirus of probable bat origin", Nature, 579, pp.270~273 (2020)
- Belouzard S, "Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites", Proc Natl Acad Sci U S A, 106, pp.5871~5876 (2009)
- Gallagher TM, "Coronavirus spike proteins in viral entry and pathogenesis", Virology, 279, pp.371~374 (2001)
- Simmons G, "Proteolytic activation of the SARS-coronavirus spike protein : cutting enzymes at the cutting edge of antiviral research", Antiviral Res, 100, pp.605~614 (2013)
- Song W, "Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2", PLoS Pathog, 14, pp.e1007236~ (2018)
- Ou X, "Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV", Nat Commun, 11, pp.1620~ (2020)
- Lokman SM, "Exploring the genomic and proteomic variations of SARS-CoV-2 spike glycoprotein : a computational biology approach", Infect Genet Evol, 84, pp.104389~ (2020)
- Li F, "Structure of SARS coronavirus spike receptor-binding domain complexed with receptor", Science, 309, pp.1864~1868 (2005)
- Yan R, "Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2", Science, 367, pp.1444~1448 (2020)
- Simmons G, "Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry", Proc Natl Acad Sci U S A, 102, pp.11876~11881 (2005)
- Shang J, "Cell entry mechanisms of SARS-CoV-2", Proc Natl Acad Sci U S A, 117, pp.11727~11734 (2020)
- Wrapp D, "Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation", Science, 367, pp.1260~1263 (2020)
- Donoghue M, "Heart block, ventricular tachycardia, and sudden death in ACE2 transgenic mice with downregulated connexins", J Mol Cell Cardiol, 35, pp.1043~1053 (2003)
- Li G, "Assessing ACE2 expression patterns in lung tissues in the pathogenesis of COVID-19", J Autoimmun, 112, pp.102463~ (2020)
- Oudit GY, "Angiotensin-converting enzyme 2 is an essential regulator of heart function", Circulation, 106, pp.315~315 (2002)
- Li W, "Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus", Nature, 426, pp.450~454 (2003)
- Korber B, "Tracking changes in SARS-CoV-2 spike : evidence that D614G increases infectivity of the COVID-19 virus", Cell, 182, pp.812~827 (2020)
- Yuan Y, "Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains", Nat Commun, 8, pp.15092~ (2017)
- Kim D, "The architecture of SARS-CoV-2 transcriptome", Cell, 181, pp.914~921 (2020)